Literature DB >> 31922980

Toward a new definition of glaucomatous optic neuropathy for clinical research.

Jayant Iyer1,2, Jayme R Vianna3, Balwantray C Chauhan3, Harry A Quigley1.   

Abstract

PURPOSE OF REVIEW: A process is ongoing to produce a definition of glaucomatous optic neuropathy (GON) using quantitative, objective data from structural and functional tests. At present, a common practice is to define GON by subjective features said to be 'characteristic' as judged by those experienced in glaucoma care. RECENT
FINDINGS: An objective definition would standardize the comparison of clinical research results across studies, without precluding simultaneous use of idiosyncratic definitions in the same reports. To achieve this goal, expert opinion was solicited to reach optimal agreement on one or more consensus, GON definitions. An interactive period of online discussion by 176 international experts led to 110 responses in an online survey that narrowed possible definitional structures into testable criteria.
SUMMARY: Two approaches to validation of one or more sets of criteria for definite and possible GON are ongoing. The general principles include definition for each eye individually, inclusion of a borderline category, no intraocular pressure criterion, and both structural and functional defects in appropriate physical locations. Each validation approach uses clinician diagnosis as a standard against which objective criteria are compared, with the initial approach using a three-level categorical scale, and the second approach using 0--100 scaling.

Entities:  

Mesh:

Year:  2020        PMID: 31922980     DOI: 10.1097/ICU.0000000000000644

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  9 in total

1.  Rationale and Development of an OCT-Based Method for Detection of Glaucomatous Optic Neuropathy.

Authors:  Jeffrey M Liebmann; Donald C Hood; Carlos Gustavo de Moraes; Dana M Blumberg; Noga Harizman; Yocheved S Kresch; Emmanouil Tsamis; George A Cioffi
Journal:  J Glaucoma       Date:  2022-02-28       Impact factor: 2.290

Review 2.  Big data requirements for artificial intelligence.

Authors:  Sophia Y Wang; Suzann Pershing; Aaron Y Lee
Journal:  Curr Opin Ophthalmol       Date:  2020-09       Impact factor: 3.761

3.  NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function.

Authors:  Fang Fang; Pei Zhuang; Xue Feng; Pingting Liu; Dong Liu; Haoliang Huang; Liang Li; Wei Chen; Liang Liu; Yang Sun; Haowen Jiang; Jiangbin Ye; Yang Hu
Journal:  Mol Ther       Date:  2022-01-31       Impact factor: 12.910

4.  A Case for the Use of Artificial Intelligence in Glaucoma Assessment.

Authors:  Joel S Schuman; Maria De Los Angeles Ramos Cadena; Rebecca McGee; Lama A Al-Aswad; Felipe A Medeiros
Journal:  Ophthalmol Glaucoma       Date:  2021-12-22

5.  An objective structural and functional reference standard in glaucoma.

Authors:  Eduardo B Mariottoni; Alessandro A Jammal; Samuel I Berchuck; Leonardo S Shigueoka; Ivan M Tavares; Felipe A Medeiros
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

6.  Clinical Evaluations of Macular Structure-Function Concordance With and Without Drasdo Displacement.

Authors:  Janelle Tong; Jack Phu; David Alonso-Caneiro; Sieu K Khuu; Michael Kalloniatis
Journal:  Transl Vis Sci Technol       Date:  2022-04-01       Impact factor: 3.048

7.  Prediction of visual field defects from macular optical coherence tomography in glaucoma using cluster analysis.

Authors:  Janelle Tong; David Alonso-Caneiro; Michael Kalloniatis; Barbara Zangerl
Journal:  Ophthalmic Physiol Opt       Date:  2022-05-22       Impact factor: 3.992

8.  An Evaluation of a New 24-2 Metric for Detecting Early Central Glaucomatous Damage.

Authors:  Donald C Hood; Abinaya A Thenappan; Emmanouil Tsamis; Jeffrey M Liebmann; C Gustavo De Moraes
Journal:  Am J Ophthalmol       Date:  2020-08-07       Impact factor: 5.258

9.  Differential Activation of Glioprotective Intracellular Signaling Pathways in Primary Optic Nerve Head Astrocytes after Treatment with Different Classes of Antioxidants.

Authors:  Anita K Ghosh; Vidhya R Rao; Victoria J Wisniewski; Alexandra D Zigrossi; Jamie Floss; Peter Koulen; Evan B Stubbs; Simon Kaja
Journal:  Antioxidants (Basel)       Date:  2020-04-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.